Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer

Journal of Urology

Volumn 167, Issue 1, 2002, Pages 123-126

  Gardner, B G ^a,b   Zietman, A L ^a,b   Shipley, W U ^a,b   Skowronski, U E ^a,b   McManus, P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Prostate; Prostatic neoplasms; Radiotherapy; Treatment outcome

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CYSTECTOMY; HEMATURIA; HUMAN; MALE; MORBIDITY; PHOTON; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION HAZARD; RECTUM HEMORRHAGE; RISK ASSESSMENT; UROGENITAL TRACT MALFORMATION;

EID: 0036136707     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65395-5     Document Type: Article

References (18)

1. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
2. Residual disease following radical surgery or radiation therapy for prostate cancer: Clinical significance and therapeutic implications
3. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future
4. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: Results of a dose escalation study
5. Dose escalation with 3-D conformal radiation therapy affects the outcome in prostate cancer
6. Conformal proton therapy for prostate carcinoma
7. Radiation therapy alone in the treatment of the uterine cervix. II. Analysis of complications
8. Proton radiation as boost therapy for localized prostatic carcinoma
9. Protons or megavoltage x-rays as boost therapy for patients irradiated for localized prostatic carcinoma. An early phase I/II comparison
10. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
11. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Cancer Research and treatment of Cancer (EORTC)
12. Late effects toxicity scoring: The SOMA scale
13. Nonparametric estimation from incomplete observations
14. Preliminary results of a randomized dose-escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer
15. Conformal irradiation of the prostate: Estimating long-term rectal bleeding risk using dose volume histograms
16. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer
17. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy
18. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer